ALLOGENE OUTLINES PLAN FOR ~100 ALPHA3 SITES BY YEAR END AS FDA GRANTS RMAT AND FAST TRACK FOR CEMA-CEL - SEEKINGALPHA

ALLOGENE OUTLINES PLAN FOR ~100 ALPHA3 SITES BY YEAR END AS FDA GRANTS RMAT AND FAST TRACK FOR CEMA-CEL - SEEKINGALPHA